Inflammatory infiltration, fibrosis, necrosis and mucinous content in relation to clinicopathological and molecular factors in rectal cancers with or without preoperative radiotherapy

Oncology Reports

Volumn 16, Issue 2, 2006, Pages 321-327

  Knutsen, Annica ^a   Adell, Gunnar ^a   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Inflammatory infiltration; Necrosis; Prognosis; Radiotherapy; Rectal cancer

Indexed keywords

MUCIN;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; FIBROSIS; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; NECROSIS; PATHOLOGY; RECTUM TUMOR;

ADULT; AGED; FEMALE; FIBROSIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUCINS; NECROSIS; RECTAL NEOPLASMS;

EID: 33748529947     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.2.321     Document Type: Article

References (22)

1. Nagtegaal ID, Marijnen C, Kranenbarg EK, et al: Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study. BMC Cancer 1: 7, 2001.
2. Shia J, Guillem JG, Moore HG, et al: Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 28: 215-223, 2004. (Pubitemid 38124730)
3. Gao J-F, Arbman G, Wadhra T, Zhang H and Sun X-F: The relationships of tumour inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers. World J Gastroenterol 11: 2179-2183, 2005. (Pubitemid 40542667)
4. Arancia G, Malorni W and Donelli G: Cellular mechanisms of lymphocyte-mediated lysis of tumor cells. Ann Ist Super Sanita 26: 369-384, 1990.
5. Ueno H, Jones AM, Wilkinson KH, Jass JR and Talbot IC: Histologic categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53: 581-586, 2004. (Pubitemid 38372985)
6. Adachi Y, Mori M, Kuroiwa S, Sugimachi K and Enjoji M: Histopathologic evaluation of survival time in patients with colorectal carcinoma. J Surg Oncol 42: 219-224, 1989. (Pubitemid 20010181)
7. Kip1 of mucinous carcinomas of the colorectum. Am J Clin Pathol 117: 908-915, 2002.
8. Swinson D, Jones L, Richardson D, Cox G, Edwards J and O'Byrne K: Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer 37: 235-240, 2002. (Pubitemid 35291153)
9. Lammering G, Taher MM, Gruenagel HH, Borchard F and Porschen R: Alterations in DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer. Clin Cancer Res 6: 3215-3221, 2000. (Pubitemid 30637750)
10. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable cancer. N Engl J Med 336: 980-987, 1997.
11. Adell GC, Zang H, Evertsson S, Sun XF, Stål OH and Nordenskjöld BA: Apoptosis in rectal cancer: Prognosis and recurrence after preoperative radiotherapy. Cancer 91: 1870-1875, 2001. (Pubitemid 32424113)
12. Adell GC, Sun X-F, Stål O, Klintenberg C, Sjödahl R and Nordenskjöld B: p53 status: An indicator for the effect of preoperative radiotherapy in rectal cancer. Radiother Oncol 51: 169-174, 1999. (Pubitemid 29320311)
13. Pachkoria K, Zang H, Adell G, Jarlsfelt I and Sun XF: Significance of COX-2 expression in rectal cancers with or without radiotherapy. Int J Radiat Oncol Biol Phys 63: 739-744, 2005. (Pubitemid 41400060)
14. Klintrup K, Mäkinen J, Kauppila S, et al: Inflammation and prognosis in colorectal cancer. Eur J Cancer 41: 2645-2654, 2005. (Pubitemid 41607555)
15. Barth R, Camp B, Martuscello T, Dain B and Memoli V: The cytokine microenviroment of human colon carcinoma: Lymphocyte expression of tumor necrosis factor-α and interleukin-4 predicts improved survival. Cancer 78: 1168-1178, 1998. (Pubitemid 26303881)
16. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al: Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 197: 20-27, 2002. (Pubitemid 34450160)
17. Martin M, Lefaix J-L and Delanian S: TGF-β1 and radiation fibrosis: A master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47: 277-290, 2000. (Pubitemid 30236366)
18. Ebert EC: Inhibitory effects of transforming growth factor-beta (TGF-β) on certain functions of intraepithelial lymphocytes. Clin Exp Immunol 115: 415-420, 1999.
19. Gorelik L and Flavell R: Immune-mediated eradication of tumours through the blockade of transforming growth factor-β signaling in T cells. Nat Med 7: 1118-1122, 2001.
20. Vujaskovic Z, Mitchell S, Anscher M, et al: Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50: 851-855, 2001.
21. Bizik J, Kankuri E, Ristimäki A, Taieb A, Vapaatalo H, Lubitz W and Vaheri A: Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ 11: 183-195, 2004. (Pubitemid 38159642)
22. Subbarayan V, Sabichi A, Llansa N, Lippman S and Menter D: Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cells. Cancer Res 61: 2720-2726, 2001. (Pubitemid 32685860)